Open AccessEfficacy of CRISPR-Cas9 CAR T-Cell Therapy vs. Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia
Author(s) -
Khushi Rathod,
Shravani Rani,
Shreerachita Satish
Publication year - 2021
Publication title -
undergraduate research in natural and clinical science and technology (urncst) journal
Language(s) - English
Resource type - Journals
ISSN - 2561-5637
DOI - 10.26685/urncst.227
Subject(s) - crispr , chimeric antigen receptor , medicine , blinatumomab , immunology , t cell , cell therapy , leukemia , immunotherapy , genetic enhancement , cancer research , immune system , oncology , cell , biology , lymphoblastic leukemia , gene , biochemistry , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom